Acetylsalicylic acid Completed Phase 1 Trials for Sickle Cell Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00178464Aspirin Prophylaxis in Sickle Cell Disease